Gen9
Gene synthesis technology that enables the high-throughput, automated production of dna constructs.
Launch date
Employees
Market cap
-
Enterprise valuation
$7—10m (Dealroom.co estimates Sep 2011.)
San Jose California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $500k | Seed | |
| N/A | $1.7m | Seed | |
$1.5m | Seed | ||
| N/A | $1.7m | Seed | |
| N/A | $395k | Debt | |
$21.0m | Growth Equity VC | ||
$25.0m | Growth Equity VC | ||
N/A | Acquisition | ||
| Total Funding | $51.4m | ||
Related Content
Recent News about Gen9
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.